ScienceNews Science News By Tomoki Todo on Tuesday, March 18, 2025 Nature Medicine, Published online: 18 March 2025; doi:10.1038/s41591-025-03619-5 Author Correction: Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial Read More Previous Post Next Post Related Posts ScienceNews Science News ScienceNews Science News ScienceNews Science News
Comments
No Trackbacks.